- KR₩70bn
- KR₩73bn
- KR₩16bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.24 | ||
| Price to Tang. Book | 0.24 | ||
| Price to Free Cashflow | 42.73 | ||
| Price to Sales | 4.37 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.44% | ||
| Return on Equity | 1.77% | ||
| Operating Margin | -26.07% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 21,901.1 | 10,318.78 | 8,416.31 | 9,598 | 16,006.6 | n/a | n/a | -1.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -77.53 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
AP Healthcare Inc, formerly Aprogen Healthcare & Games Inc, is a Korea-based company engaged in the manufacture and sale of pharmaceutical products. The Company mainly operates in four business segments. The Pharmaceutical segment provides medicines for digestive system, integumentary, nutrients and tonics and antibiotic preparations. The Insulation segment provides insulation products for refineries and other plants. The Rental segment provides office and laboratory rental services. The Other segment mainly provides business support services.
Directors
- Jae Seop Kim CEO (53)
- Chang Yong Jung MDR (45)
- Jeong Gwon Lee MDR (45)
- Yu Chan Kim OTH (43)
- Hyeong Gi Kim OTH (60)
- Jang Wun Park OTH (45)
- Je Wu Park OTH (36)
- Jin Cheol Jung DRC (43)
- Sun Gyu Park DRC (49)
- Xinhui Wu DRC (36)
- Wei Zhao DRC (32)
- Wei Zhou DRC (36)
- Seong Hui Kang NID (44)
- Su Taek Yim NID (60)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 12th, 1998
- Public Since
- November 13th, 2009
- No. of Shareholders
- 11,490
- No. of Employees
- 65
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ- Shares in Issue
- 114,117,026
- Address
- B1, SEONGNAM, 13215
- Web
- http://www.aprogen-hng.com/
- Phone
- +82 3180220595
- Auditors
- Daejoo Accounting Corp.
Upcoming Events for 109960
Similar to 109960
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
Ahn-Gook Pharmaceutical Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:02 UTC, shares in AP Healthcare are trading at KR₩613. This share price information is delayed by 15 minutes.
Shares in AP Healthcare last closed at KR₩613 and the price had moved by -56.18% over the past 365 days. In terms of relative price strength the AP Healthcare share price has underperformed the FTSE Developed Asia Pacific Index by -54.26% over the past year.
There is no consensus recommendation for this security.
AP Healthcare does not currently pay a dividend.
AP Healthcare does not currently pay a dividend.
AP Healthcare does not currently pay a dividend.
To buy shares in AP Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩613, shares in AP Healthcare had a market capitalisation of KR₩70bn.
Here are the trading details for AP Healthcare:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 109960
Based on an overall assessment of its quality, value and momentum AP Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AP Healthcare. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -45.17%.
As of the last closing price of KR₩613, shares in AP Healthcare were trading -38.13% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The AP Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩613.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
AP Healthcare's management team is headed by:
- Jae Seop Kim - CEO
- Chang Yong Jung - MDR
- Jeong Gwon Lee - MDR
- Yu Chan Kim - OTH
- Hyeong Gi Kim - OTH
- Jang Wun Park - OTH
- Je Wu Park - OTH
- Jin Cheol Jung - DRC
- Sun Gyu Park - DRC
- Xinhui Wu - DRC
- Wei Zhao - DRC
- Wei Zhou - DRC
- Seong Hui Kang - NID
- Su Taek Yim - NID